Chiral resolution, determination of absolute configuration, and biological evaluation of (1,2-benzothiazin-4-yl)acetic acid enantiomers as aldose reductase inhibitors

作者: Xin Hao , Xiangyu Qin , Saghir Hussain , Shagufta Parveen , Wei Zhang

DOI: 10.3109/14756366.2014.961447

关键词:

摘要: A novel series of (1,2-benzothiazin-4-yl)acetic acid enantiomers was prepared by chiral resolution, and their absolute configurations were determined using the PGME method. The biological evaluation racemate single has shown a remarkable difference for aldose reductase inhibitory activity selectivity. (R)-(-)-enantiomer exhibited strongest with an IC(50) value 0.120 μM, which 35 times more active than S-(+)-enantiomer. Thus, stereocenter at C4 position this scaffold to have major impact on

参考文章(26)
D. K. Moczulski, W. Burak, A. Doria, M. Zychma, E. Zukowska-Szczechowska, J. H. Warram, W. Grzeszczak, The role of aldose reductase gene in the susceptibility to diabetic nephropathy in Type II (non-insulin-dependent) diabetes mellitus (Short Communication) Diabetologia. ,vol. 42, pp. 94- 97 ,(1999) , 10.1007/S001250051119
Selma Hayman, Jin H. Kinoshita, ISOLATION AND PROPERTIES OF LENS ALDOSE REDUCTASE. Journal of Biological Chemistry. ,vol. 240, pp. 877- 882 ,(1965) , 10.1016/S0021-9258(17)45256-2
Kiichi Sawai, Kyoichi Asano, Kuniharu Mizuno, Yasuaki Kondo, Naofumi Terada, Ryoichi Unno, Hiroshi Ozawa, Kenji Miura, Masayasu Kurono, Masato Fukushima, Noriaki Kato, Akira Matsubara, Toshinao Usui, Takuji Yamaguchi, Hydantoin derivatives for treating complications of diabetes ,(1987)
Luca Costantino, Giulio Rastelli, Paola Vianello, Giorgio Cignarella, Daniela Barlocco, Diabetes complications and their potential prevention: aldose reductase inhibition and other approaches. Medicinal Research Reviews. ,vol. 19, pp. 3- 23 ,(1999) , 10.1002/(SICI)1098-1128(199901)19:1<3::AID-MED2>3.0.CO;2-7
Barbara Kasprzyk-Hordern, Pharmacologically active compounds in the environment and their chirality Chemical Society Reviews. ,vol. 39, pp. 4466- 4503 ,(2010) , 10.1039/C000408C
Xin Chen, Shuzhen Zhang, Yanchun Yang, Saghir Hussain, Minlan He, Dequan Gui, Bing Ma, Chaojun Jing, Zhixin Qiao, Changjin Zhu, Qun Yu, 1,2-Benzothiazine 1,1-dioxide carboxylate derivatives as novel potent inhibitors of aldose reductase Bioorganic & Medicinal Chemistry. ,vol. 19, pp. 7262- 7269 ,(2011) , 10.1016/J.BMC.2011.07.051
Katja Šturm, Lea Levstik, Vassilis J. Demopoulos, Albin Kristl, Permeability characteristics of novel aldose reductase inhibitors using rat jejunum in vitro. European Journal of Pharmaceutical Sciences. ,vol. 28, pp. 128- 133 ,(2006) , 10.1016/J.EJPS.2006.01.006
Federico Da Settimo, Giampaolo Primofiore, Antonio Da Settimo, Concettina La Motta, Francesca Simorini, Ettore Novellino, Giovanni Greco, Antonio Lavecchia, Enrico Boldrini, Novel, highly potent aldose reductase inhibitors: cyano(2-oxo-2,3-dihydroindol-3-yl)acetic acid derivatives. Journal of Medicinal Chemistry. ,vol. 46, pp. 1419- 1428 ,(2003) , 10.1021/JM030762F
Tomoichiro Asano, Yasushi Saito, Masanobu Kawakami, Nobuhiro Yamada, Fidarestat (SNK-860), a potent aldose reductase inhibitor, normalizes the elevated sorbitol accumulation in erythrocytes of diabetic patients Journal of Diabetes and Its Complications. ,vol. 16, pp. 133- 138 ,(2002) , 10.1016/S1056-8727(01)00175-1
K. H. Gabbay, L. O. Merola, R. A. Field, Sorbitol Pathway: Presence in Nerve and Cord with Substrate Accumulation in Diabetes Science. ,vol. 151, pp. 209- 210 ,(1966) , 10.1126/SCIENCE.151.3707.209